Treatment for hepatitis C virus in human immu- nodeficiency virus-infected patients: clinical ben- efits and cost-effectiveness. Arch Intern Med 2002; 162:2545-56.Kuehne, F.C., et al., Treatment for hepatitis C virus in human immunodeficiency virus-infected patients: clinical benefits and ...
Cost-effectiveness of screening for hepatitis C in Canada. The seroprevalence of hepatitis C virus (HCV) infection among Canadians is estimated at 0.3% to 0.9%. Of those with chronic HCV infection, 10% to 20% will ... WL William,Wong,Hong-Anh,... - CMAJ : Canadian Medical Association ...
摘要: Background Limited data is available on Hepatitis C disease prevalence, treatment initiation and its cost-effectiveness in Lebanon and the whole Middle East. ObjectiveThe aim of the study is to...关键词...
The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection. Annals of Internal Medicine. 2015;162(9):619-26.52Linas BP, Barter DM, Morgan JR, et al. The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C genotypes...
Hepatitis C virus (HCV) infection remains a significant medical concern in the United States and around the world. It is still one of the leading causes of chronic liver disease, and, for more than 20 years, there has been little progress in the treatment of HCV infection. The advent of ...
Background The prevalence of diagnosed chronic hepatitis C virus (HCV) infection among pregnant women in the Netherlands is 0.26%, yet many cases remain undiagnosed. HCV screening and treatment of pregnant HCV carriers could reduce the burden of disease and limit vertical transmission from mother to...
摘要: Discusses the cost-effectiveness of treatments for chronic hepatitis C. Cost-effectiveness of interferon treatment and combination therapy; Hepatitis C virus decision model; Efficacy of initial interferon treatment of chronic hepatitis C in prolonging life expectancy....
Treatment Alternatives for Chronic Hepatitis B Virus Infection: A Cost-Effectiveness Analysis Background: Treatment options for chronic hepatitis B virus (HBV) infection have disparate risks and benefits. Interferon has clinically significant side effects, and lamivudine is associated with viral resistance....
Nearly 40% of human immunodeficiency virus- (HIV-) infected veterans on highly active antiretroviral therapy (HAART) in the United States are coinfected with hepatitis C virus (HCV). With the increased survival due to declining opportunistic infections as a result ...
"In our office we use only thenewest treatmentsfor hepatitis C. These are thenewly FDA approved drugsavailable in the last 18 months. We no longer use interferon, in fact we don't use interferon at all. There are many patients out there who have chronic hepatitis C and when they think ...